Tag: Hikma Pharmaceuticals

Hikma Reports Strong H1 2026 Results, Reaffirms Full-Year Outlook

Hikma Pharmaceuticals reported 4% revenue growth to $1.728 billion in H1 2026,…

ME Desk

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Pfizer has reached settlement agreements with multiple generic manufacturers over VYNDAMAX (tafamidis),…

ME Desk